Department of Surgery Archive — Page 1 of 14

June 2, 2026

Resilient Stage 4 colon cancer patient discovers surgery option close to home  

Vanderbilt-Ingram Cancer Center is “pushing the envelope” with new technologies like histotripsy and new programs like robotic liver surgery and robotic pancreas surgery, serving patients not only from Tennessee, but also parts of Kentucky, Alabama and Georgia.  

March 18, 2026

Motor protein plays key role in intestinal stem cell identity, function

Study findings suggest a new therapeutic approach for a rare digestive disorder, microvillus inclusion disease.

March 3, 2026

Vanderbilt Health and Bertis establish collaboration for cancer drug discovery

The collaboration will integrate Vanderbilt Health’s Molecular AI Initiative capabilities with Bertis’ deep proteomics and AI-enabled technologies to identify novel therapeutic targets and predictive biomarkers.

Before being sedated, Aaron Davis gives a thumbs up with his surgical team. (photo by Donn Jones)
February 12, 2026

Vanderbilt Health celebrates milestone for novel histotripsy procedure 

Appealing to patients for its noninvasive nature, it avoids many of the traditional drawbacks of surgeries that use incisions, including pain management. 

Some members of the Critical Care Outreach Team at Vanderbilt University Hospital include, front row, left to right, Casey Ernfelt, ACNP, Lindsay Trantum, ACNP, Rebekah Pike, ACNP. Back row, left to right, Liza Weavind, MBBCh, Cody Bowers, AG-ACNP, Kipp Shipley, DNP, Megan Shifrin, DNP, ACNP-BC, and Christopher Hughes, MD. (photo by Donn Jones)
January 13, 2026

Critical Care Outreach Team’s rapid response interventions improve patient safety, prevent ICU transfers

Since January 2020, members of the VUH CCOT have responded to more than 10,000 rapid response calls in every non-ICU unit in the adult hospital.

January 9, 2026

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The retrospective study analyzed the electronic health records of 1,257 patients ages 18 to 65 who underwent bariatric surgery at Vanderbilt Health from 2017 to 2022, and 1,809 patients treated with the drugs semaglutide or tirzepatide from 2018 to 2023.